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Objective: The authors determined the seroprevalence of HIV-1 among patients admitted
to two psychiatric hospitals in New York City. Method: Patients consecutively admitted to an
acute psychiatric unit in Manhattan and a large state hospital in Queens were anonymously
tested for HIV-1 antibodies from December 1 989 through July 1 990. Test results were linked
to age, gender, ethnicity, and two risk behaviors: male homosexual activity and injection drug
use. Results: Blood was obtained from 83.0% ofthe eligible patients. The prevalence of HI V
was 5.5% (25 of4Sl). Black patients accounted for 38.0% ofthe patients tested and 76.0%
of positive results (N=l 9), a rate of 1 1 . I % for this group. The rate of seropositivity was
comparable in women and men. Clinicians had charted risk behavior for nine (36.0%) of the
25 HIV-positive patients. Infection control records suggested that clinicians were aware of
seven (28.0%) of the positive cases. Conclusions: One in every 1 8 patients admitted to two
public psychiatric hospitals in New York City was HIV positive. Clinical staff largely failed
to identify HIV-positive patients. Ethnicity and a history ofhomosexual activity among men
or use ofinjected drugs were strongly associated with seropositivity. This pattern of infection
may be linked to needle sharing and/or sexual activity with partners who have shared needles.
Future research should clarify how psychiatric illness affects risk-taking behavior, focus on
improving detection by clinicians, and identify effective prevention strategies in this population.
(Am J Psychiatry 1991; 148:1225-1230)
W e have seen an alarming increase in HIV infection
among the severely mentally ill. The 4,000-bed
state hospital system in New York City identified its
first case of AIDS in 1983. By 1988, 24 patients who
were openly tested that year were positive for HIV-1
antibodies, and in 1989 the number had increased to 53
newly tested HP/-positive patients ( 1 ). In addition to
known cases, an unknown number of infected psychi-
atnic patients with risk-taking histories who do not con-
sent to HIV antibody testing or who do not report risk
behaviors are being cared for in psychiatric hospitals.
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The severely mentally ill as a group are vulnerable to HIV
infection because of comombidity with substance abuse
(2). Psychiatric diagnosis and substance abuse appear
to be related (3-6), leading many investigators to hy-
pothesize a self-medication effect (3, 5-7). Chronic
substance abuse may also precipitate and exacerbate
psychosis (8, 9). Smokable cocaine (crack) and injection
drugs are among the substances used by psychiatric
patients and are highly associated with HIV infection
(10-15).
Unsafe sexual behavior, including sex with strangers
or with partners who inject drugs, has also been me-
ported among the severely mentally ill ( 1 6-23), and
psychiatric symptoms are likely to affect patients’ per-
ceptions of their own HIV risk and efficacy in prevent-
ing infection (24).
At present little is known about the prevalence of
HIV infection among psychiatric patients. Zampenetti
et al. (25) reported that 6.5% of 475 patients admitted
to a psychiatric ward in Milan oven 2 years were HIV
positive. In an ongoing study of patients admitted to
acute cane psychiatric units in a private hospital in New
York City, Sacks et al. found that of 254 patients be-
tween the ages of 1 8 and 55 years who were anony-
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mously tested for HP/-i, 20 were positive, a mate of
7.9% (VI International Conference on AIDS, 1990).
One-half of the seropositive patients reported male ho-
mosexual activity, and one-quarter reported either in-
jection drug use or sex with a partner who injected
drugs. In another ongoing study, nine (7.3%) of 124
patients admitted to a psychiatric unit for the homeless
were reported positive for HIV-1 (Empfield et al., VI
International Conference on AIDS, 1990).
METHOD
Patients and Procedure
We tracked patients between the ages of 1 8 and 59
years who were consecutively admitted to two psychi-
atmic hospitals in New York City from December 1989
through July 1 990. One site was a 22-bed acute cane
unit at an academic medical center in northern Manhat-
tan mandated to accept all patients referred from the
local catchment area; 1 33 eligible patients were admit-
ted to this unit. The other site was a large state hospital
providing acute and chronic cane to the borough of
Queens; 413 eligible patients were admitted here. Both
settings are state funded and mandated to treat severe
mental illness. Most patients are either uninsured or
have Medicaid. Any patient with a primary diagnosis of
either dementia on substance abuse is excluded by pol-
icy from admission.
Following current federal regulations for anonymous
sampling (26), we obtained discard blood samples from
blood drawn for routine purposes at the time of admis-
sion. Patients whose discard blood was not obtained on
admission were tracked for subsequent blood workup.
Samples could not be obtained for every patient because
of patient refusal of blood tests, patient discharge be-
fore blood drawing, or insufficient quantity. Blood
samples were obtained for 456 of the 546 patients. We
kept a record of every patient admitted so that we
would obtain only a single sample of blood from each
patient even if individual patients were admitted more
than once during the study period. This patient roster
was destroyed after all the discard blood samples were
obtained.
Patient chart number, date of birth, admission diag-
nosis, and number of previous psychiatric hospitaliza-
tions were obtained from each patient’s chart and me-
corded on the top half of a two-part form to obtain
profiles of the eligible patients unlinked with HIV
status. Age range, gender, ethnicity, known use of in-
jected drugs, and history of homosexual activity among
men were obtained from the patient chart and recorded
on the lower half of the form. Because few Asian pa-
tients are admitted to either hospital, Asians were
grouped with Caucasians to avoid the possibility of
identifying any HIV-positive Asian patient. After demo-
graphic and risk factors were ascertained, the patient
identification (upper) section of the form was removed
and a six-digit ban-code number was affixed to the
lower section to link the blood sample with the demo-
graphic and risk factor data.
The blood samples were stored, frozen, and sent in
batches of at least 25 to the New York Blood Center
for antibody testing. Specimens that were shown to be
reactive by enzyme-linked immunosombent assay
(ELISA) were tested with the Western Blot and then
classified according to current recommendations of
the Centers for Disease Control (27). A specimen was
considered positive if antibodies to two of the follow-
ing were detected: p24, gp4l, and gpl2O/160. The
presence of any single band on the Western Blot con-
stituted an indeterminate result. Because the sampling
was anonymous, obtaining a second specimen for
retesting from patients whose test results were incon-
clusive was not possible.
Data Analysis
A group profile of the tested patients, unlinked to
their blood specimens, provided descriptive clinical
data, including admission diagnosis and number of pne-
vious psychiatric hospitalizations. Linking of the blood
test results with the patients’ demographic chanac-
tenistics and HIV risk behaviors provided prevalence
mates within subgroups. All data were measured at
either a nominal on ordinal level; therefore, contingency
table analysis was used to interpret the data. Chi-squame
and Bartholomew’s tests were performed, and odds na-
tios were used to estimate relative risk. Adjusted odds
ratios were derived from logistic regression coefficients.
Statistical significance was expressed in exact values,
with the exception of the result of the Bartholomew’s
test, which was expressed as significant on not signifi-
cant. The criterion for significance was set at an alpha
level of 0.05.
RESULTS
Of the 456 samples sent to the New York Blood Cen-
ten for antibody testing, three were reported to be too
small for testing. Of the 453 samples tested, 28 (6.2%)
were reactive according to ELISA. Two of these showed
indeterminate results on Western Blot and were omitted
from the analysis of relative risk and serostatus. Of the
remaining 26 samples that were reactive on ELISA, 25
were confirmed positive by Western Blot. This results
in a seroprevalence rate of 5.5% (25 of 451). The dis-
tribution of positive results is shown in table 1. One
sample that was reactive according to ELISA was nega-
tive according to Western Blot.
Of the 1 33 eligible patients admitted to the 22-bed
Manhattan unit during the study period, 128 were
tested for HIV. Of the 41 3 eligible patients admitted to
the state hospital in Queens during the study period,
325 were tested. Eight (6.3%) of the 128 tested samples
from the acute unit were positive, and 17 (5.2%) of the
325 tested samples from the state hospital in Queens
were positive. The mates at the two sites were not statis-
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Interval px2 df p
Age (years)1’ 0.46c 3 n.s. 1.35 0.55-3.32 1.27 0.48-3.34 0.62
18-29 142 9 6.34
30-39 155 9 5.81
40-49 110 5 4.55
50-59 44 2 4.55
Ethnicity’ 17.79 2 0.0001 5.63 2.20-14.40 6.33 2.39-16.73 0.0002
Black 172 19 11.05
Hispanic I I S S 4.35
CaucasianlAsian 163 1 0.61
Sex 0.22 1 0.64 1.21 0.54-2.72 2.23 0.84-5.93 0.11
Male 237 12 5.06
Female 214 13 6.07
Injection drug use 5974 I 0.02 3.76 1.41-10.06 - - -
Identified 39 6 15.38
Not identified 412 19 4.61
Homosexual activity
in men (N=237) 3.16t I 0.08 4.67 1.14-19.07 - - -
Identified 18 3 16.67
Not identified 219 9 4.11
Any risk factor 12.18e I 0.0005 4.76 1.99-11.40 7.58 2.69-21.36 0.0001
Identified 54 9 16.67
Not identified 397 16 4.03
Total 451 25 5.54
Two patients had indeterminate results and were omitted from this analysis.
Comparison groups for calculating the odds ratios for age were 18-39 and 40-49 years.
Bartholomew’s test for increasing proportions (trend).
N=450 because ethnicity was not recorded for one seronegative patient. Comparison groups for calculating the odds ratios for ethnicity were
black and nonblack.
eWith continuity correction.
tically different (20.18, df=1, p=O.67). Site as a van-
able was omitted from further analysis because of this
nonsignificant difference.
In total, we tested 453 of the 546 admitted patients,
or 83.0%. Theme were no significant differences in age
or gender between the patients whose blood we ob-
tamed and those we did not. Qiucasian and Asian pa-
tients were represented somewhat less among the blood
samples collected than among those not collected.
Blood was not obtained for 15.5% ofthe black patients
and 10.0% of the Hispanics, whereas for the Caucasian!
Asian group, blood samples for 21.6% were not ob-
tamed (x28.12, df2, pO.O2).
As a group, the 456 sampled patients had the fol-
lowing admission diagnoses: schizophrenia, N=206
(45.2%); schizoaffective disorder, N=39 (8.6%); affec-
tive disorder, N=1 14 (25.0%); other psychotic disom-
dens, N=53 (1 1.6%); all other diagnoses, N=42 (9.2%),
including two patients with unknown diagnoses. Num-
ben of known previous psychiatric hospitalizations was
as follows: zero hospitalizations, N=65 (14.3%); one
hospitalization, N=49 (10.7%); two to five hospitaliza-
tions, N=297 (65. 1 %); more than five hospitalizations,
N=4S (9.9%). There were no significant differences be-
tween the sampled patients and the patients whose
blood was not obtained in diagnosis (20.72, df=3,
p=O.87) on number of previous hospitalizations
(t=0.44, df=109.8, p=O.66).
When we examined the linked risk histories of the
seropositive patients, clinicians had identified risk be-
havion in nine (36.0%) of the 25 patients. Among the
12 WV-positive men, six (50.0%) had known risk be-
havions. Three (25.0%) used injected drugs, and three
(25.0%) had histories of homosexual activity. Among
the 13 HIV-positive women, three (23.1 %) injected
drugs. Of the 428 seronegative patients, 33 (7.7%)
were identified as injection drug users. Of the 225 sero-
negative men, 15 (6.7%) had histories of homosexual
activity. Relative risk estimations were derived with un-
adjusted odds ratios to compare the risks of testing
positive for HIV-1 antibodies among the patients with
and without identified risk factors. Unadjusted odds ma-
tios calculate relative risk for each factor without con-
trolling for effects of other risk variables. The unad-
justed odds ratios showed that identified injection drug
users were almost four times as likely to be senopositive
as patients without histories of injection drug use.
Overall, the risk of being seropositive was five times as
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high for the patients with known histories of at least
one of the measured risk behaviors as for those who did
not have such histories. The association of serostatus
with demographic and behavioral risk factors is pre-
sented in table 1.
Using multiple logistic regression to simultaneously
analyze the effects of several independent variables on
HIV status, we found ethnic group and behavioral risk
factors to independently contribute to the likelihood of
being HIV senopositive. The adjusted odds ratios show
that the risk for blacks was six times that of subjects in
other ethnic groups, and the chance of having a positive
Western Blot result for patients with one on more be-
haviomal risks was seven and one-half times the risk for
other patients.
The unadjusted and adjusted estimations of relative
risk demonstrate essentially the same relationship be-
tween risk factors and HIV seropositivity. Thus, ethnic-
ity and behavioral risk factors independently increase
the likelihood of testing positive for HIV-1 antibodies.
DISCUSSION
Most of the patients in our study were psychotic and
had multiple psychiatric admissions. The most common
clinical diagnosis was schizophrenia, and 75.0% of the
patients had had two or more hospitalizations before the
index admission. The 5.5% prevalence of HIV indicates
that certain severely mentally ill patients are at risk for
HIV infection. A history of risk behavior was charted by
clinicians for only 36.0% of the senopositive patients. Dc-
spite this low rate of recorded risk, a history of risk be-
havion, either homosexual activity among men on injec-
tion drug use, predicted H1V semopositivity.
The results of this study suggest several conclusions
regarding the pattern of HIV infection among an urban,
severely and chronically ill psychiatric population.
First, the highest rates of infection are among black pa-
tients. In our group, one in nine black patients was HIV
positive. Second, women are as likely to be infected as
men. Third, a record of risk behavior is likely to be
found for only a minority of patients.
Having learned that women in this population are as
likely to be infected as men, we must make active efforts
to identify their risk-taking behaviors, which include
having sexual partners who inject drugs. Recent data
(28) show that for New Jersey and New York, HIV!
AIDS is the leading cause of death for black women
aged 15-44 years. This HP//AIDS death mate is nine
times that for Caucasian women of the same age. It is
not clear to what extent differences in infection rates
between black, Hispanic, and white women are caused
by differences in risk behavior, exposure to infected
sexual or needle-shaming partners, and biological vul-
nerability to HIV infection.
The pattern of infection we found also suggests a link
to injection drug use. The New York City Department
of Health (29) reported that for 49.7% of the black and
Hispanic men in New York City with known cases of
AIDS, use of injected drugs is the primary risk factor.
Among all women with AIDS in New York City, injec-
tion of drugs is the primary risk factor for 6 1 .5% and
sex with men at risk is the primary risk factor for
24. 1 %. In contrast, among white men with AIDS, only
12.4% report injection of drugs as their primary risk
behavior. Given that in our group 76.0% of the scro-
positive subjects were black and 52.0% were women,
injection of drugs and having sexual partners who in-
ject drugs are likely to be major factors in how psychi-
atmic patients acquire HP! infection.
The rate of HIV infection in our subjects does not
simply mirror other rates in the New York City area.
The mate of 5.5% in our subjects is intermediate among
reported rates in a number of clinical settings in New
York City. For example, the New York City Depart-
ment of Health (30) performed prevalence studies in
1 988-1 989 and found the following lower rates of HIV
infection among 6,325 tested patients: abortion clinics,
1.6%; sentinel hospital A, 1.4%; sentinel hospital B,
2.7%. A 1988 study of the mentally retarded living in
the metropolitan New York City region (3 1) showed no
HIV-positive subjects among 241 clients whose blood
was tested. On the other hand, our mate was lower than
that reported for the high-risk patients seen in New
York City clinics for sexually transmitted diseases (32).
Theme, 8.8% of 8,931 patients tested in 1988 and 1989
were positive for HIV-1 infection.
Our study sites are in areas of New York City with
low to moderate mates of AIDS cases. In June 1 990, the
rates of AIDS cases in the city varied by zip code from
57 cases to 1,802 cases pen 100,000 population (29).
The range in the neighborhoods we drew our patients
from was 65 to 348 cases pen 100,000 population. Sig-
nificantly higher rates might be found on psychiatric
units with patients from areas of the city with higher
rates of AIDS. The reported seroprevalence rate is, nev-
ertheless, an estimate of the minimum percent of AIDS
cases we will eventually see in our population.
Anonymous seroprevalence studies have advantages
and disadvantages. An anonymous study does not iden-
tify the patient on require that any extra blood be
drawn. Because theme is no impact on the patient, con-
sent is not required. This method allows investigators
to test larger groups of patients, thereby increasing sta-
tistical power and nepresentativeness without self-selec-
tion bias and without interfering with clinical judgment
about the risks and benefits of testing for any individual
patient. Patients who might otherwise refuse HIV test-
ing or be unable to give informed consent can be in-
cluded. On the other hand, because the study is not per-
formed with the consent of the patient, it is impossible
to conduct structured diagnostic or risk assessment in-
tcrviews. Our study therefore had to depend on the in-
formation available in hospital records. We did not link
blood samples to psychiatric diagnosis because admis-
sion diagnoses are not as reliable as those established
by research interviews. We did not want to draw emno-
neous conclusions about the relationship between HIV
status and psychiatric diagnosis.
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The anonymous survey method poses an ethical
problem because it determines the presence of HIV-
positive people within a group without allowing identi-
fication, counseling, and medical cane. Identification of
HIV-positive psychiatric patients might result in addi-
tional stigmatization of this chronically and severely ill
population. These disadvantages had to be weighed
against the value of establishing their prevalence of
HIV. We concluded that the information gained would
be essential to planning for the needs of a large number
of severely mentally ill patients and therefore the bene-
fits of obtaining a full epidemiological picture out-
weighed the disadvantages of the method.
Sampling limitations also may have affected our me-
sults. Because Caucasians and Asians were ovemnepre-
sented among the 17.0% of admitted patients for
whom we did not obtain blood, we may have overesti-
mated HIV prevalence in our subjects. On the other
hand, our findings probably underestimate the preva-
lence of HIV-1 among psychiatric patients from neigh-
borhoods in New York City with higher concentrations
of HIV. We did not extract chart information about
sexual partners who injected drugs on were HIV posi-
tive. The existing literature led us to bias our question-
name in favor of recording risk behavior among men. In
addition, chart review may have underestimated the cli-
nicians’ knowledge of their patients. Clinical staff may
have had knowledge about risk behavior that they did
not record, either to maintain confidentiality or because
it seemed irrelevant for charting purposes.
Independent of our study, the clinicians at the two
hospitals involved in our investigation are required to
report known HIV-positive patients to hospital infec-
tion control nurses. During the same period in which
our anonymous study determined 25 patients to be HIV
positive, the infection control nurses recorded seven
HIV-positive patients. We cannot validate the accuracy
of the infection control records, and we do not know
whether any of the seven reported cases were among
our patients for whom blood samples were not avail-
able. However, this observation suggests that, at best,
clinicians were aware of only seven of the 25 HIV-posi-
tive patients identified by the anonymous survey.
Clinical staff at the large state hospital reported two
HP/-positive patients to infection control committees.
This compares to the 1 7 seropositive patients who were
found by the anonymous study. On the small acute came
unit, five HIV-positive patients were reported by clini-
cal staff to the infection control committee, and the
anonymous study found eight seropositive patients.
Therefore, the low rates of risk behavior charted by cli-
nicians seem consistent with the small number of HIV-
positive patients identified by them.
Risk behaviors were detected for all the HIV-positive
patients reported to the infection control committees.
Of the seven patients who were known to be HIV posi-
tive, two (28.6%) were men and five (71.4%) were
women. One man was identified as having injected
drugs, and one had a female sexual partner with HIV!
AIDS. One of these patients was black, and one was
Hispanic. Of the five women identified by clinicians as
HIV positive, two were black and three were Hispanic.
Among the women, three were identified as users of in-
jected drugs, three used cocaine, one had a history of
prostitution, and four were identified as having sexual
partners who injected drugs. It is clean that once some-
one tests positive for HIV, risk-taking behaviors are
more aggressively investigated. However, many in-
fected people are passing through undetected, making
early intervention impossible.
When risk taking is identified, appropriate counsel-
ing and serologic testing with patient consent is mdi-
cated. This should be done in the context of clinical
cane. We believe the issue of mandatory testing is not
one that the mental health system should attempt to
address independently. Psychiatric patients deserve the
same consideration as other groups when individual
rights and public health interests are balanced. For
most groups, the current approach is to encourage test-
ing with informed consent but not to require it. Given
sufficient clinical attention, many infected patients can
be identified. The small acute care unit in our study,
which has a high physician-to-patient ratio, was more
successful at this task than the large state hospital,
which has less physician oversight. However, even at
the state hospital, it may be possible to overcome this
problem by developing systematic procedures for in-
quining about HIV-misk behavior.
In an ongoing study, we are collecting seroprevalence
data from homeless and long-stay units and risk assess-
ment interview data from multiple units at the two hos-
pitals. These data will allow us to develop a prediction
model for HIV infection and AIDS cases and to exam-
inc how psychiatric symptoms and risk are related. We
hope to find ways to protect the considerable number
of risk-taking psychiatric patients who are antibody
negative and to reduce the risk of transmission by those
who are already infected. We believe these efforts are
uniquely within the province of psychiatry and urge ad-
ditional efforts in this area.
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